About Max
This author has not written his bio yet.
But we are proud to say that Max contributed 854 entries already.
Entries by Max
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Can We Predict Deep PSA Response Before Treatment Starts? NADIR Validated in ARCHES September 29, 2026
- Carboplatin Shows Activity in HRR-Altered Metastatic Prostate Cancer September 29, 2026
- Newsletter 39/2026 September 27, 2026
- Neuromedin U: A New Way Neuroendocrine Prostate Cancer May Hide From the Immune System September 25, 2026
